Ranexa
Ranolazine 500mg and 1000mg prolonged-release tablets, used in the management of stable angina pectoris. It blocks the late sodium current.
All strengths and pack prices
| Strength | Pack | Price | Per unit |
|---|---|---|---|
| 500mg | 30 tablets | US$89.40 | US$2.98 |
| 500mg | 60 tablets | US$127.80 | US$2.13 |
| 500mg | 90 tablets | US$168.30 | US$1.87 |
| 500mg | 120 tablets | US$204.00 | US$1.70 |
| 500mg | 180 tablets | US$271.80 | US$1.51 |
| 1000mg | 30 tablets | US$102.00 | US$3.40 |
| 1000mg | 60 tablets | US$189.00 | US$3.15 |
| 1000mg | 90 tablets | US$229.50 | US$2.55 |
| 1000mg | 120 tablets | US$285.60 | US$2.38 |
| 1000mg | 180 tablets | US$383.40 | US$2.13 |
- Category
- Heart & Blood Pressure
- Active ingredient
- Ranolazine
- Route
- Oral use
- Form
- Prolonged-release tablet
- Strengths
- 500 · 1000mg
You will receive a quality generic equivalent, depending on stock.
No prescription needed: we place your order for Ranexa on your behalf.
- Condition
- Angina Pectoris
- Therapeutic class
- Anti-anginal Drug
- Pharmacological class
- Late Sodium Current Inhibitor
- Minor side effects
- dizziness; constipation; nausea; headache
- Moderate side effects
- fatigue; asthenia; blurred vision
- Dosage forms
- Prolonged-release tablet
- Administration route
- Oral use
- Originator
- Menarini
- Onset time
- 1–2 days
- Duration
- 24 hours
- Drug interactions
- ketoconazole; verapamil; diltiazem; simvastatin
- Age restrictions
- Not recommended for those under 18 years.
- Pregnancy and breastfeeding
- Pregnancy: Not recommended. Breastfeeding: Not recommended.
Contraindications
hypersensitivity; severe renal impairment; severe hepatic impairment; concurrent use of potent CYP3A4 inhibitors
Precautions and warnings
monitor for arrhythmias; use caution in elderly patients; regular electrocardiogram monitoring required
Serious side effects
qt prolongation, requires immediate medical attention; ventricular arrhythmias, requires immediate medical attention; syncope, requires immediate medical attention
Patient summary
Ranolazine 500mg and 1000mg prolonged-release tablets, used in the management of stable angina pectoris. It blocks the late sodium current.
Mechanism of action
This medicine inhibits the late sodium current in heart muscle cells, which prevents sodium and calcium overload, improving cardiac relaxation and blood flow efficiency.
Storage instructions
Store at room temperature, keep in original packaging, and protect from moisture.
Ranexa contains Ranolazine, a recognised treatment for chronic, stable angina pectoris. This medication is supplied as a tablet in strengths of 500mg and 1000mg. It is frequently chosen by patients seeking a reliable method to manage heart-related chest pain symptoms.
Buying Ranexa online
A reliable supply chain ensures that consistent access is maintained regardless of current location.
What you will receive
Ranexa is the originator brand name, made by Menarini. We use it here to identify the medicine only; we are not affiliated with Menarini and do not ship the original Ranexa.
- You receive a generic equivalent: the same active ingredient (Ranolazine) at the same dose, mostly recognised Indian branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- Inactive ingredients, tablet appearance and packaging can differ from the original brand; the active ingredient and dose are the same.